Introduction {#s02}
============

The *lacY* gene, the second structural gene in the *lac* operon ([@bib40]), encodes lactose permease (LacY), the polypeptide solely responsible for β-galactoside transport in *Escherichia coli*. LacY (TCDB 2.A.1.5.1) is a member of the oligosaccharide/H^+^ symporter subfamily of the major facilitator superfamily (MFS), and it recognizes disaccharides with a D-galactopyranosyl ring and D-galactose, with no affinity for glucopyranosides or glucose. The natural substrate of LacY is lactose, a disaccharide containing a galactopyranosyl and a glucopyranosyl motiety in a β-1→4 glycosidic linkage. LacY catalyzes reversible translocation of one galactoside with one H^+^, and coupled translocation in the same direction is obligatory (symport).

The *lacY* gene is the first gene encoding a membrane transport protein to be cloned and sequenced ([@bib3]), the first symporter to be purified to homogeneity in a functional state ([@bib41]) and the first symporter to have a structure determined ([@bib1]). LacY has 417 amino acid residues (65--70% of which are hydrophobic) and a molecular weight of 46,517 D, and each of the 417 residues has undergone Cys-scanning mutagenesis (reviewed in [@bib11]) and site-directed alkylation (reviewed in [@bib32]; [@bib43]) and/or other site-directed mutagenesis. Notably, only nine residues are essentially irreplaceable with regard to active lactose transport: Glu126 (helix IV), Arg144 (helix V), Trp151 (helix V), Tyr236 (helix VII), Glu269 (helix VIII), Asn272 (helix VIII), and His322 (helix X) form the galactoside-binding site ([@bib35], [@bib36]); and Arg302 (helix IX) and Glu325 (helix X) are essential for coupled H^+^ translocation ([@bib4]; [@bib49]). All nine side chains are located in or near the aqueous cavity in the approximate middle of the LacY molecule ([Fig. 1 a](#fig1){ref-type="fig"} and [Fig. 2 a](#fig2){ref-type="fig"}).

![**X-ray crystal structure of WT LacY (PDB accession no. [2V8N](2V8N)).** LacY molecule in an inward-facing conformation. In the ribbon representations of LacY (a and b), the N- and C-terminal six transmembrane helices are colored in blue and green, and the middle cytoplasmic loop is colored yellow. **(a)** Viewed perpendicular to the membrane with helices V and VIII in front. The sidedness of the membrane is labeled. **(b)** Cytoplasmic view normal to the membrane. Helices are labeled in roman numerals. **(c--f)** Calculated electrostatic surface potential of LacY molecule. The scale indicates color-coded values of the electrostatic potentials (kT/e). **(c and d)** Viewed perpendicular to the membrane. **(e and f)** Viewed parallel to the membrane from cytoplasmic and periplasmic sides.](JGP_201912377_Fig1){#fig1}

![**Mutant G46W/G262W and galactoside binding.** Crystal structures of the LacY G46W/G262W mutant in a partially outward-facing occluded conformation with bound α-NPG (PDB accession no. [4ZYR](4ZYR)) or TDG (PDB accession no. [4OAA](4OAA)). Both lactose analogues are shown in black. **(a)** Slab view of a surface representation of the LacY G46W/G262W molecule revealed by crystallography (PDB accession no. [4ZYR](4ZYR)). An occluded α-NPG molecule is shown as sticks. **(b)** Binding interactions of α-NPG with LacY. **(c)** Binding interactions of TDG with LacY. The helices of LacY are colored in rainbow and labeled with roman numerals. Side chains that directly contact the sugar are shown as sticks. Dotted lines indicate interactions between the sugar and the protein, as well as between residues. The number in red indicates the hydroxyl group position in galactopyranosyl ring.](JGP_201912377_Fig2){#fig2}

LacY is a chemiosmotic nano-machine that performs coupled transport of a galactopyranoside with an H^+^ across the cytoplasmic membrane of *E. coli* (i.e., galactoside/H^+^ symport). Active transport (i.e., transport against a concentration gradient) is achieved by transduction of the free energy released from energetically favorable movement of H^+^ down the electrochemical H^+^ gradient ($\Delta{\widetilde{\mu}}_{H^{+}};$ interior negative and/or alkaline) as postulated by the chemiosmotic hypothesis of [@bib38], [@bib39]; [Fig. 3 a](#fig3){ref-type="fig"}). Conversely, downhill galactoside transport drives uphill H^+^ flux and generation of $\Delta{\widetilde{\mu}}_{H^{+}},$ the polarity of which depends upon the direction of the sugar concentration gradient ([Fig. 3, b and c](#fig3){ref-type="fig"}). Importantly, LacY also catalyzes transmembrane exchange of internal for external galactoside in a manner that is independent of $\Delta{\widetilde{\mu}}_{H^{+}}$ ([Fig. 3, d and e](#fig3){ref-type="fig"}). Thus, the primary driving force for "alternating access" ([@bib27]) of the H^+^- and sugar-binding sites to either side of the membrane is binding and dissociation of galactoside by protonated LacY. Without bound sugar, LacY cannot translocate H^+^ with or without $\Delta{\widetilde{\mu}}_{H^{+}},$ and unprotonated LacY cannot bind a galactoside because of low affinity. Therefore, binding of both sugar and H^+^ is required for symport.

![**Transport reactions catalyzed by LacY**. **(a)** Active transport. The electrochemical H^+^ gradient ($\Delta{\widetilde{\mu}}_{H^{+}}$) across the cytoplasmic membrane of *E. coli* is generated by efflux of H^+^ via the respiratory chain or through the hydrolytic activity of F~1~F~o~ ATPase. Free energy released from the energetically favored downhill movement of H^+^ catalyzed by LacY (yellow) is converted to the uphill accumulation of lactose as indicated by the direction of the arrows and font size. **(b)** Influx. **(c)** Efflux. Energetically downhill lactose transport generates $\Delta{\widetilde{\mu}}_{H^{+}},$ the polarity of which depends upon the direction of lactose concentration gradient (influx generates a $\Delta{\widetilde{\mu}}_{H^{+}}$ that is interior positive and acid; efflux generates a $\Delta{\widetilde{\mu}}_{H^{+}}$ that is interior negative and alkaline). **(d)** Equilibrium exchange. At equal intra- and extracellular lactose concentrations, lactose exchange across the membrane is catalyzed by protonated LacY. **(e)** Counterflow. At a high intracellular and low extracellular lactose concentrations, transient influx of radiolabeled external lactose or "counterflow" across the membrane is observed. The reaction is catalyzed by protonated LacY. Lac, lactose; SH, substrate in a reduced form.](JGP_201912377_Fig3){#fig3}

Despite a number of structures of MFS members, including 10 of LacY, mechanisms of these dynamic proteins are not completely understood. It has been demonstrated that sugar binding to highly dynamic protonated LacY triggers a global conformational change in which sugar- and H^+^-binding sites gain alternating access to either side of the membrane. Sugar binding and dissociation drive this conformational change through an induced-fit mechanism, while the proton electrochemical gradient accelerates the rate of deprotonation. LacY behaves much like an enzyme except that the transition state involves the protein rather than the substrate. X-ray structures of LacY inward- and almost occluded outward-facing conformations provide the structural basis for the alternating access mechanism. Alternating access has been documented almost unequivocally by applying pre--steady-state kinetics, as well as multiple biochemical and spectroscopic approaches, and by using kinetic data obtained in real time for several steps in the transport cycle. Thirty-one camelid nanobodies (Nbs) allow stabilization of LacY in different intermediate states that are providing an understanding of the structural changes underlying the symport mechanism.

Oligomeric state {#s03}
================

LacY is a monomer both in detergent and in the membrane. The polypeptide reconstitutes as a monomer, as shown by fluorescence anisotropy ([@bib66]) and by freeze-fracture EM in the absence or presence of an imposed $\Delta{\widetilde{\mu}}_{H^{+}}~$ ([@bib6]). Initial rates of $\Delta{\widetilde{\mu}}_{H^{+}} -$driven lactose transport in proteoliposomes reconstituted at various protein-to-lipid ratios vary linearly. The linearity of the data and particularly the complete lack of sigmoidicity at very low ratios are consistent with the conclusion that LacY functions as a monomer. Furthermore, an engineered fusion protein encoded by two tandemly fused *lacY* open reading frames exhibits good transport activity, and negative dominance is not observed with either mutations or chemical modification in either half of the covalent dimer ([@bib50]). Finally, cross-linking of LacY single-Cys mutants in the plane of the membrane is stochastic ([@bib19]). Taken together, the findings indicate that LacY is both structurally and functionally a monomer (reviewed in [@bib18]).

3-D structure {#s04}
=============

LacY is organized into two six-helix bundles connected by a relatively long cytoplasmic loop between helices VI and VII, which exhibit twofold pseudo-symmetry when viewed parallel to the plane of the membrane ([Fig. 1, a and b](#fig1){ref-type="fig"}). Within each domain, there are two three-helix repeats with inverted topology. These structural features are observed in both inward- and outward-facing conformations. The protein is 86% α-helix in the x-ray structure (85% by circular dichroism; [@bib10]) and contains twelve transmembrane helices traversing the membrane in zigzag fashion connected by very short hydrophilic loops with both N and C termini on the cytoplasmic side of the membrane. Most of the helices are irregular and distorted with bends and kinks. Helices III, VI, IX, and XII are largely embedded in the membrane, and the cytoplasmic regions of helices I, II, IV, and V from the N-terminal domain and helices VII, VIII, X, and XI from the C-terminal domain line a hydrophilic cavity. The inward-facing conformation may represent the resting state of the molecule ([@bib42]; [@bib57]; [@bib30]).

The initial structure was obtained with a conformationally constrained mutant, C154G LacY ([@bib1]), and a similar crystal structure was obtained for the WT a few years later ([@bib22]). Viewed perpendicular to the membrane, both structures display heart-shaped molecules with a deep hydrophilic cavity open on the cytoplasmic side and sealed on the periplasmic side, an inward (cytoplasmic)--facing conformation ([Fig. 1 a](#fig1){ref-type="fig"}) with largest dimension of 60 × 60 Å. Viewed parallel to the plane of the membrane from the cytoplasmic side ([Fig. 1 b](#fig1){ref-type="fig"}), the molecules have a distorted oval shape that measures 30 × 60 Å. Calculation of the electrostatic surface potential reveals a positively charged ring around the cytoplasmic opening ([Fig. 1, c--e](#fig1){ref-type="fig"}; [@bib72]) and preferential distribution of negatively charged residues on the periplasmic side ([Fig. 1 f](#fig1){ref-type="fig"}). It is apparent that LacY conforms to the positive inside rule ([@bib68]). Remarkably, LacY can be expressed in two fragments in vivo that find each other in the membrane and form a functional complex ([@bib2]; [@bib73]).

Four x-ray structures from LacY mutant G46W/G262W in a partially outward (periplasmic)--open conformation with a tightly sealed cytoplasmic side ([@bib35], [@bib36], [@bib37]; [@bib28]) have also been obtained ([Fig. 2 a](#fig2){ref-type="fig"}). Three of the structures (8, 9, and 27) are in an occluded conformation with a narrow periplasmic opening and a single galactoside molecule in the central sugar-binding site. The opening on the periplasmic side is too narrow to allow entrance or exit of the sugar (∼3 Å at the narrowest point), and the bound galactoside is occluded. Mutant G46W/G262W is clearly able to open sufficiently to bind galactoside at rates approaching diffusion ([@bib58]), and upon binding, the mutant tries to transit into an occluded conformation. However, it cannot do so completely because the bulky Trp residues block complete closure. Thus, the mutant binds galactoside, which initiates transition into an occluded intermediate state, but it cannot complete the operation, which accounts for why the mutant is completely unable to catalyze transport of any type. It is also clear that an occluded intermediate is part of the transport cycle.

Galactoside binding and specificity {#s05}
===================================

There is one sugar-binding site in LacY that is selective for galactose or disaccharides containing a galactosyl moiety, and the symporter transports a single molecule per transport cycle. Two lactose analogues, β-D-galactopyranosyl 1-thio-β-D-galactopyranoside (TDG) and 4-nitrophenyl-α-D-galactopyranoside (α-NPG), as well as other homologues ([@bib62]), bind to LacY with micromolar *K*~d~. The natural substrate lactose has poor affinity with a *K*~d~ of ∼1 mM ([@bib17]), and galactose is the most specific substrate for LacY with the lowest affinity. Various adducts (particularly if they are hydrophobic) at the anomeric carbon (C~1~) of the galactopyranosyl ring greatly increase affinity with little or no effect on specificity ([@bib51]). Although glucose is an epimer of galactose, neither glucose nor glucosides are recognized by LacY. The C~4~ OH on the galactopyranosyl ring is probably the most important determinant for specificity, with the C~5~, C~3~, and C~6~ OH groups playing varying roles in determining affinity/specificity, while C~1~ and C~2~ OH are of little importance ([@bib51], [@bib52]).

Sugar-bound LacY in the inward-facing or partially outward-facing conformation has been resolved crystallographically ([@bib5]; [@bib35], [@bib36], [@bib37]). Both of the inward-facing and outward-facing structures contain a single galactoside that occupies the central cavity lined by the same residues regardless of the conformation of LacY, further confirming the conclusion that there is only a single sugar-binding site ([@bib17]). The site is located at the apex of the internal cavity in the middle of LacY, which enables transport in either direction.

The sugar-bound, inward-facing structure is from single-Cys V122C LacY with covalently bound methanethiosulfonyl-galactoside ([@bib5]), a suicide inactivator for the mutant ([@bib21]). Sugar-bound outward-facing structures have been obtained for the G46W/G262W mutant ([@bib58]) with bound TDG or α-NPG ([@bib35], [@bib36], [@bib37]). The position of the galactosyl moiety in these structures is almost identical ([Fig. 2, b and c](#fig2){ref-type="fig"}), which provides strong evidence that it is indeed the galactosyl moiety that determines specificity.

Cys-scanning and site-directed mutagenesis have been used extensively to study the sugar-binding site in LacY ([@bib11]), and the results from genetic engineering in combination with biochemical and biophysical characterization are largely confirmed crystallographically ([@bib5]; [@bib35], [@bib36], [@bib37]). The LacY structures show that the galactopyranosyl ring of α-NPG or TDG stacks hydrophobically with Trp151 in helix V ([Fig. 2, b and c](#fig2){ref-type="fig"}), which is suggested to play important roles in orienting the galactopyranosyl ring and facilitating specific hydrogen bonding, in addition to increasing affinity ([@bib20]). Replacement of Trp151 with a Tyr or Phe residue decreases affinity for galactosides, but has little effect on lactose transport ([@bib20]; [@bib64]; [@bib55]). Glu269 in helix VIII forms two hydrogen bonds with the C~4~ and C~3~ OH groups on the galactopyranosyl ring ([Fig. 2, b and c](#fig2){ref-type="fig"}), which explains why the Glu269 residue may be the primary determinant for sugar specificity ([@bib71]). These important interactions are further stabilized by hydrogen bond interactions between the C~4~ and C~3~ OH with Asn272 (helix VIII) and between His322 (helix X) and the C~3~ OH. The Asn272 side chain can be replaced with Gln exclusively without a significant loss of sugar-binding affinity. Glu269 and His322 are irreplaceable with respect to sugar-binding and transport activities. Two other irreplaceable residues, Arg144 and Glu126 in the N-terminal domain, form a salt bridge, and Arg144 serves directly as a hydrogen-bond donor to the C~5~ and C~6~ OH groups of the galactopyranosyl ring of TDG or α-NPG, and the C~2′~ OH group in another galactopyranosyl ring. As described above, the glucopyranosyl ring in lactose can be replaced by various adducts that affect binding affinity only. Glu126, in addition to stabilizing the position of Arg144, also forms multiple hydrogen bonds with the C~2′~ and C~3′~ OH groups of TDG. Arg144 cannot be replaced with positively charged Lys, and Asp replacement for Glu126 also decreases affinity for galactosides significantly ([@bib54]).

Sugar binding and induced fit {#s06}
=============================

Methanethiosulfonyl-galactose is a unique suicide substrate for a LacY mutant with Cys in place of Ala122 ([@bib21]). The x-ray structure ([@bib5]) reveals that a molecule of methanethiosulfonyl-galactose is covalently bound to a Cys engineered at position 122 near the sugar-binding site, and the overall conformation of LacY remains in an inward-open conformation, although typically galactoside binding shifts LacY to the outward-open state (reviewed in [@bib57]). However, many side-chain interactions with the galactopyranoside ring are perturbed; for example, Asn272, His322, and Arg144 are no longer sufficiently close to interact with the galactopyranosyl ring. Therefore, although the binding site is partially occupied, critical interactions with these important side chains are sufficiently disturbed that the interactions are insufficient to drive transition into the occluded state.

H^+^ binding {#s07}
============

Unexpectedly, LacY exhibits a perturbed apparent p*K* of ∼10.5 with respect to galactoside-binding affinity, and the pH-dependent apparent p*K* is abrogated when Glu325 (helix X) is replaced with a neutral side chain ([@bib53]; [Fig. 4](#fig4){ref-type="fig"}). Mutant E325A binds sugar with an affinity similar to WT, but affinity is independent of pH up to at least pH 11. Even more remarkably, Glu325 also exhibits a p*K*~a~ of 10.5 by direct measurement with surface enhanced infrared absorption spectroscopy (SEIRAS; [@bib15]; [Fig. 5](#fig5){ref-type="fig"}). The perturbed p*K*~a~ is due to location in a hydrophobic pocket between helices IX and X ([Figs. 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Therefore, Glu325 is clearly the primary (and possibly the only) functional H^+^-binding site in LacY. A p*K*~a~ value of 10.5 translates to a *K*~d~ for H^+^ of less than ∼30 pM, so Glu325 is completely protonated over a very broad pH range. The overall conclusion is that the galactoside-binding site in LacY is remarkably stable to alkaline pH, but in order to elicit this property, Glu325 must be replaced with a neutral side chain.

![**p*K*~a~ of Glu325 in LacY.** The pH dependence of Δ-IR intensity change at 1,742 cm^−1^ was measured with the LacY G46W/G262W mutant in the absence or presence of α-NPG (filled red circles) or E325A LacY (open red circles). The *K*~d~ values for α-NPG binding to WT LacY (filled green circles), E325A LacY (open green circles), or LacY G46W/G262W mutant (filled cyan circles) were calculated as the ratio of rate constants (k~off~/k~on~) measured by stopped-flow fluorescence.](JGP_201912377_Fig4){#fig4}

![**Position of Glu325 in WT LacY (PDB accession no. [2V8N](2V8N)).** LacY is presented as rainbow-colored backbone (from blue to red for helices I to XII) with a hydrophilic cavity open to the cytoplasmic side. The side chain of Glu325 in helix X is shown as spheres. The area around Glu325 is enlarged with the hydrophobic environment displayed as a space-filled cartoon (cyan).](JGP_201912377_Fig5){#fig5}

![**Environment of Glu325.** Crystal structure of the LacY G46W/G262W mutant in an outward-facing partially occluded conformation (PDB accession no. [4OAA](4OAA)). Helices of LacY are colored in rainbow and labeled with roman numerals. Dotted lines indicate polar/charged side chains/OH groups that are in close proximity and may form salt-bridge/H-bond interactions. TDG is shown in black, and C~3~ OH is indicated. Glu325 is in helix X.](JGP_201912377_Fig6){#fig6}

Of potential importance, Glu325 is in close proximity to an electrostatic/hydrogen-bond network involving His322 and Lys319 on helix X, Tyr236 and Asp240 on helix VII, and Arg302 on helix IX ([Fig. 6](#fig6){ref-type="fig"}). Glu269 and particularly His322, initially thought to be involved in H^+^ translocation, are both ligands for the galactopyranosyl moiety in the sugar-binding site ([Fig. 2, b and c](#fig2){ref-type="fig"}). Mutation of Glu269, His322, or Tyr236 causes a marked decrease in sugar-binding affinity ([@bib53]). Another salt bridge (Asp237 in helix VII and Lys358 in helix XI) also lies in the cavity, but does not make a direct contact with either site and is not involved in sugar or H^+^ binding. However, this salt bridge is essential for the insertion of LacY into the membrane and for maintaining protein stability ([@bib31]).

Since transmembrane exchange does not involve $\Delta{\widetilde{\mu}}_{H^{+}},$ it is apparent that alternating access is driven by binding and dissociation of sugar, and does not involve turnover of H^+^ ([@bib30]). Because the driving force for accumulation against a gradient is $\Delta{\widetilde{\mu}}_{H^{+}}$ and *E. coli* has a stable internal pH of 7.6 ([@bib44]; [@bib47]; [@bib74]), a p*K*~a~ of 10.5 for LacY ([@bib53]; [@bib15]) implies that decreasing the p*K*~a~ by three orders of magnitude to cytoplasmic pH would release only ∼50% of the transported lactose from LacY. How to increase the rate of deprotonation without decreasing the H^+^ concentration of the *E. coli* cytoplasm? Arg302 is relatively close to Glu325 (∼6 Å), and mutants R302A or R302S cannot perform active transport, but catalyze transmembrane exchange ([@bib52]; [@bib70]). A recent SEIRAS study ([@bib16]) on the effect of mutating residues in the immediate vicinity of Glu325 shows that only mutation R302K alters the Glu325 p*K*~a~, causing over a 2-pH U acid shift. Overall, the findings support the idea that H^+^ is extracted from Glu325 by spatial fluctuations in the position of Arg302, expelling H^+^ by moving near Glu325 ([@bib69]) or vice versa.

Although nothing more is known at present, neutral replacements for specific carboxyl residues in the *E. coli* melibiose ([@bib9]), fucose ([@bib7]), and xylose permeases ([@bib63]), as well as the *Staphylococcus epidermidis* glucose permease ([@bib26]), behave functionally in a manner similar to neutral replacement mutants for Glu325 in LacY. Thus, each of these sugar permease mutants is defective with respect to active transport (i.e., H^+^/sugar symport), but still able to catalyze transmembrane exchange reactions. At the least, the findings indicate that these MFS family members likely have an ordered kinetic mechanism similar to that found with LacY.

Alternating access and the symport mechanism {#s08}
============================================

An alternating-access type of mechanism is widely accepted to explain membrane transport; thus, H^+^ symporters expose both H^+^- and cargo-binding sites alternatively to either side of the membrane through conformational changes. In LacY, both the sugar- and H^+^-binding sites are located at the approximate middle of the molecule at the apex of the cavity, providing a structural basis for such an alternating-access mechanism.

The periplasmic- and cytoplasmic-open conformations with bound galactoside and H^+^ reflect static states. However, LacY must undergo dynamic conformational changes to expose both the sugar- and H^+^-binding sites to either side of the membrane. Multiple independent experimental methods ([@bib56]), e.g., site-directed alkylation of single-Cys mutants; thiol cross-linking; single molecule FRET; double electron--electron resonance spectroscopy; and time-resolved FRET techniques to detect conformational change, sugar-binding kinetics, and nanobodies, have been used to examine sugar-induced conformational changes which provide independent converging evidence that periplasmic and cytoplasmic cavities open reciprocally and that opening of the periplasmic cavity controls closing of the cytoplasmic cavity ([@bib33]; [@bib61]). In the absence of a galactoside, LacY may favor an inward-facing conformation, the resting state, as indicated by the crystal structure ([Fig. 1](#fig1){ref-type="fig"}), but galactoside binding causes LacY to populate intermediate occluded and outward-open conformations.

The LacY transport cycle includes alternating-access and several other steps that are explained by a simplified eight-step kinetic scheme ([Fig. 7](#fig7){ref-type="fig"}). Based upon an ordered-binding model ([@bib34]), different transport modes are explained in detail below.

![**The H^+^-lactose symport mechanism**. There are eight kinetic steps as indicated. H^+^ and galactoside bind in the middle of the molecule, and LacY moves around the binding sites to release the sugar and the H^+^ by an ordered mechanism on either side of the membrane as indicated by the arrows. The alternating-access process involves the shaded steps only (2--5). S, substrate; H^+^, proton.](JGP_201912377_Fig7){#fig7}

Active transport {#s09}
================

Active transport of lactose against a lactose concentration gradient is driven by $\Delta{\widetilde{\mu}}_{H^{+}}$ (interior negative and/or alkaline). LacY is completely protonated in the outward-open state, which primes it for sugar binding with relatively high affinity (1). Binding of galactoside from the periplasm (2) to protonated LacY induces the formation of an occluded intermediate (3), in which sugar and H^+^ are bound and both solvent accessible pathways from either side of protein are closed. The intermediate with a bound sugar and H^+^ then opens to the cytoplasm (4), sugar dissociates (5) followed by deprotonation of Glu325 (6) to the cytoplasm, unloaded LacY returns to the outward-facing conformation by steps (7 and 8), and Glu325 is protonated immediately (1), ready for the next transport cycle. Notably, the ordered mechanism, with H^+^ on first and off second, makes it particularly difficult to develop a H^+^ leak.

LacY drives accumulation of lactose against a 50- to 100-fold concentration gradient ([@bib48]) with a turnover number of ∼20 s^−1^. Both ΔΨ (interior negative) and ΔpH (interior alkaline) have quantitatively the same effect on transport, with a 50- to 100-fold decrease in *K*~m~ and the same thermodynamic equilibrium. In opposition to time-honored conjecture, the *K*~d~ for galactosides on either side of the membrane is essentially the same in the absence or presence of $\Delta{\widetilde{\mu}}_{H^{+}}$ ([@bib17]). In the absence of $\Delta{\widetilde{\mu}}_{H^{+}},$ there is three- to fourfold inhibition of lactose transport in the presence of deuterium oxide (D~2~O), indicating that deprotonation is rate limiting ([@bib65]; [@bib13], [@bib14]; [@bib12]). However, when there is a driving force on the H^+^ in the presence of $\Delta{\widetilde{\mu}}_{H^{+}},$ deprotonation is no longer rate-limiting, and the transport rate is unaffected by D~2~O. It is particularly noteworthy that a number of experimental findings indicate that $\Delta{\widetilde{\mu}}_{H^{+}}$ functions kinetically as a driving force on the H^+^, but alternating access itself is driven by galactoside binding and dissociation and independent of $\Delta{\widetilde{\mu}}_{H^{+}}$ ([@bib18]).

Transport down a concentration gradient {#s10}
=======================================

Inwardly directed flux (influx) or outwardly directed flux (efflux) down lactose concentration gradients ([Fig. 3, b and c](#fig3){ref-type="fig"}) occurs in a similar fashion, starting at step 1 for influx and step 6 for efflux and proceeding around the circle. Both transport modes generate $\Delta{\widetilde{\mu}}_{H^{+}},~$ the polarity of which depends on the direction of the flux, and the limiting step involves deprotonation of Glu325. Both reactions exhibit deuterium isotope effects; i.e., influx and efflux are inhibited by D~2~O.

Transmembrane exchange {#s11}
======================

Equilibrium exchange and counterflow represent alternating access of the galactoside-binding site to alternative sides of the membrane. In either reaction, LacY binds a sugar molecule on the external side of the membrane (unlabeled if equilibrium exchange; labeled if counterflow) and exchanges that sugar molecule for its opposite member on internal side of membrane. With equilibrium exchange, the concentrations are the same on both sides of the membrane; with counterflow, the internal concentration of unlabeled galactoside is much higher than the external concentration of labeled sugar. Under both conditions, the H^+^ does not dissociate from LacY, and both reactions are unaffected by ambient pH or $\Delta{\widetilde{\mu}}_{H^{+}}$ and do not exhibit a deuterium isotope effect. Only steps 2 through 5 in [Fig. 7](#fig7){ref-type="fig"} are engaged. For counterflow, the initial 1/1 exchange of internal unlabeled substrate for external labeled galactoside leads to a rapid increase in internal radioactivity until all of the internal unlabeled sugar inside is exchanged for external labeled galactoside. At this point, the increase in radioactivity stops, and the internal radioactivity decreases with time as the concentrations equilibrate and the specific activity of the external labeled substrate decreases, thereby causing the typical "overshoot" profile that is observed.

Ordered binding and release of H^+^ and galactoside are strongly supported by the behavior of neutral replacement mutants in Glu325 that do not catalyze any reactions involving net H^+^ translocation (i.e., electrogenic transport), but catalyze transmembrane exchange (i.e., electroneutral transport) at the same rate as WT LacY ([@bib4]).

Outward-facing conformers stabilized by Nbs {#s12}
===========================================

Single-domain camelid Nbs raised against a LacY mutant immobilized in an outward-open conformation bind to LacY completely inhibiting transport and stabilizing the open-outward conformers of the WT ([@bib59]). Using site-directed, distance-dependent Trp quenching/unquenching of fluorescent probes on opposite surfaces of LacY, conformational states of LacY complexed with each of eight unique, high-affinity Nbs that bind exclusively to the periplasmic side and block transport, but increase accessibility of the sugar-binding site, were examined ([@bib60]). Each Nb induces quenching with three pairs of cytoplasmic Trp/bimane probes, indicating closure of the cytoplasmic cavity. In reciprocal fashion, the same Nbs induce unquenching of fluorescence in three pairs of periplasmic probes due to opening of the periplasmic cavity. Since the extent of fluorescence change with various Nbs differs and the differences correlate with changes in the stopped-flow rate of sugar binding, it is also concluded that the Nbs stabilize several different outward-open conformations of LacY. Thus, Nb binding clearly involves conformational selection of LacY molecules, which has been confirmed by thermodynamic studies with isothermal titration calorimetry ([@bib25]). X-ray crystal structures of three Nb/LacY complexes, one apo structure ([@bib28]) with no bound sugar substrate, and two with bound lactose analogues ([@bib36], [@bib37]), confirm the biochemical data indicating that the Nbs bind stoichiometrically to the periplasmic face of the C-terminal six-helix bundle with nanomolar affinities.

IIA^Glc^ regulation of lactose utilization by catabolite repression {#s13}
===================================================================

Transcription of the *lacY* gene and LacY transport activity are down-regulated by the phosphoenolpyruvate:glucoside phosphotransferase system (PTS; [@bib46]; [@bib45]). A phosphotransfer protein IIA^Glc^ of the PTS, the most abundant cytosolic protein in *E. coli*, plays a key role in the regulating carbohydrate metabolism by binding to various families of sugar transporters and many other soluble proteins, modulating their activities ([@bib8]; [@bib23]; [@bib67]; [@bib24]). Binding measurements ([@bib24]) show that unphosphorylated IIA^Glc^ binds to LacY in the absence or presence of galactoside. Glucose transport by PTS-mediated vectorial phosphorylation ([@bib29]) leads to preponderance of unphosphorylated IIA^Glc^, which binds to LacY and inhibits galactoside binding and subsequent inducer formation. By this means, synthesis of inducer is prevented so that the cell preferentially utilizes glucose via the PTS. The phenomenon is known as "inducer exclusion."

Summary and future prospects {#s14}
============================

Studies with LacY have provided new insights into the mechanism of H^+^/galactoside symport as follows. (1) High-resolution structural information of at least two important conformations of LacY in apo and substrate-bound forms have been obtained. (2) Detailed understanding of galactoside and H^+^ binding and symport, much of which was unanticipated, has been obtained. (3) Although chemiosmosis is the driving force for the overall process by which lactose is accumulated against a concentration gradient, the basic alternating access conformational change itself is independent of $\Delta{\widetilde{\mu}}_{H^{+}}.$ (4) Active transport does not involve a change in affinity for galactoside on either side of the membrane. Rather, there is a marked change in affinity for H^+^ driven by $\Delta{\widetilde{\mu}}_{H^{+}}.~$ And perhaps most surprisingly, (5) The mechanism of coupling between H^+^ and galactoside binding is relatively simple---in order to bind/transport galactoside, Glu325 must be protonated.

Despite these advances, several fundamental questions remain unsolved, some of which are the following: How generalized are the findings with LacY with respect to other permeases? Why does a negative charge on Glu325 block galactoside binding? Is Glu325 the only side chain in LacY directly involved in coupled H^+^ translocation? Although there is no change in *K*~d~ for galactosides, why kinetically is there is a decrease in *K*~m~ in the presence of $\Delta{\widetilde{\mu}}_{H^{+}}?$ What structural changes resulting from release of sugar during the transport cycle cause LacY deprotonation? Is an increase in water accessibility involved with deprotonation of Glu325? Does the transport mechanism in other symporters involve a carboxyl side chain with a perturbed pK*~a~* that can be detected by SEIRAS? By using Nbs, can cryo-EM be applied successfully to a protein the size of LacY?
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